[1]
Kavitha.K.N. et al. 2022. EXPLORING THE POTENTIAL OF CELTIS AETNENSIS COMPOUNDS THROUGH MOLECULAR DOCKING FOR HEPATOCELLULAR CARCINOMA. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Oct. 2022), 2689–2696. DOI:https://doi.org/10.53555/jptcp.v29i04.5516.